# EDGAR Filing Document

**Accession Number:** 0001953530
**File Stem:** 0001193125-23-022765
**Filing Date:** 2023-2
**Character Count:** 2214
**Document Hash:** 689a54160a60de048d24fd25e72493a0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-022765.hdr.sgml**: 20230306

**ACCESSION NUMBER**: 0001193125-23-022765

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oculis Holding AG
- **CENTRAL INDEX KEY:** 0001953530
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** BAHNHOFSTRASSE 7
- **CITY:** ZUG
- **STATE:** V8
- **ZIP:** 6300
- **BUSINESS PHONE:** 617-937-2423

**MAIL ADDRESS:**
- **STREET 1:** BAHNHOFSTRASSE 7
- **CITY:** ZUG
- **STATE:** V8
- **ZIP:** 6300

**Oculis Holding AG** 

Bahnhofstrasse 7

CH-6300

Zug, Switzerland

February 2, 2023

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Trade & Services

100 F Street, N.E.

Washington, D.C. 20549

Attn: Li Xiao

Daniel Gordon

Daniel Crawford

Ada D. Sarmento

Re: Oculis Holding AG

Registration Statement on Form F-4

File No. 333-268201

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Oculis Holding AG, a stock corporation (*Aktiengesellschaft*) incorporated and existing under the laws of Switzerland (the "**<u>Registrant</u>**"), hereby requests acceleration of effectiveness of its registration statement on Form F-4 (File No. 333-268201), as amended, to 4:00 p.m. Eastern Time on February 3, 2023, or as soon as practicable thereafter.

The Registrant hereby authorizes Derek Dostal of Davis Polk & Wardwell LLP to orally modify or withdraw this request for acceleration.

Please contact Derek Dostal of Davis Polk & Wardwell LLP at (212) 450-4322 or derek.dostal@davispolk.com with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.

---

| |
|:---|
| Very truly yours, |
| /s/ Eduardo Bravo Fernandez de Araoz |
| Eduardo Bravo Fernandez de Araoz, Principal Executive Officer, Oculis Holding AG |

---

cc: Derek Dostal, Davis Polk & Wardwell LLP